Intelligent Bio Solutions
INBS
4 hedge funds and large institutions have $651K invested in Intelligent Bio Solutions in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 7 closing their positions.
766% more capital invested
Capital invested by funds: $75.1K → $651K (+$576K)
0.13% more ownership
Funds ownership: 0% → 0.13% (+0.13%)
50% less funds holding
Funds holding: 8 → 4 (-4)
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$968K |
| 2 |
Walleye Capital
New York
|
+$735K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$22K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$918 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$23K |
| 2 |
Renaissance Technologies
New York
|
-$21K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$13.9K |
| 4 |
State Street
Boston,
Massachusetts
|
-$6.82K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.38K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $367K | +$968K | +1,055 | New |
|
|
2
Walleye Capital
New York
| $274K | +$735K | +801 | New |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $8K | +$22K | +24 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $1.78K | +$918 | +1 | +25% |
|
5
Wells Fargo
San Francisco,
California
| $17 | – | – | – |
|
|
6
Geode Capital Management
Boston,
Massachusetts
| – | -$23K | -48 | Closed |
|
|
7
Renaissance Technologies
New York
| – | -$21K | -44 | Closed |
|
|
8
Citadel Advisors
Miami,
Florida
| – | -$13.9K | -29 | Closed |
|
|
9
State Street
Boston,
Massachusetts
| – | -$6.82K | -14 | Closed |
|
|
10
Vanguard Group
Malvern,
Pennsylvania
| – | -$3.38K | -7 | Closed |
|
11
Jane Street
New York
| – | -$2.24K | -5 | Closed |
|
|
SG
12
StoneX Group
New York
| – | -$2.63K | -5 | Closed |
|
INBS Hedge Fund Activity: Q1 2023 in Review
4 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Intelligent Bio Solutions (INBS) for Q1 2023, worth a combined $651K — up 766% from $75.1K a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of INBS and 3 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Sabby Management, opening a new position worth an estimated $968K. The largest seller was Geode Capital Management, exiting entirely with an estimated $23K sold.
- 4 institutional investors held Intelligent Bio Solutions (INBS) as of Q1 2023, down from 8 in Q4 2022.
- Funds reported $651K of Intelligent Bio Solutions stock for Q1 2023, up 766% quarter-over-quarter.
- 3 funds opened new Intelligent Bio Solutions positions in Q1 2023 and 7 closed out, a net change of -4 holders.
- The largest Intelligent Bio Solutions buyer in Q1 2023 was Sabby Management, an estimated $968K added.
- The largest Intelligent Bio Solutions seller in Q1 2023 was Geode Capital Management, an estimated $23K sold.
Based on aggregated 13F filings for Q1 2023.